Ahead of print

If you wish to receive notifications about publication of new articles, click here to register as reader

Table of Contents

open access

Original articles (submitted)

Real-world experience of treatment individualization based on fixed-dose combination of gliclazide extended release+ metformin extended release in type 2 diabetes mellitus

Sanjay Kalra, Aravinda Jagadeesha, Deepak Khandelwal, Kirti Samudra, Sharvil Gadve, Supratik Bhattacharyya

Research paper

DOI: 10.5603/DK.a2021.0042

Real-world evidence on the effectiveness and safety of gliclazide extended release treatment in Indian patients with type 2 diabetes undergoing Ramadan fast: an analysis from the global DIA-RAMADAN study

Shehla Shaikh, Sunil Dhand, Supratik Bhattacharyya, K. Modi, S. Moazam, Sharat S Kolke, Yogesh Kadam, Syed Nazim Ahmad, T. Sivagnanam, Kunal Kundan

Research paper

DOI: 10.5603/DK.a2021.0041

Impact of probiotic intake on the glycemic control, lipid profile and inflammatory markers among patients with type 2 diabetes mellitus

Azza Ismail, Olfat Darwish, Dalia Tayel, Dalia Elneily, Gihan Elshaarawy

Research paper

DOI: 10.5603/DK.a2021.0037

Study of serum progranulin level and its relation to microvascular complications in subjects with type 1 diabetes mellitus

Kamel Rohoma, Mabaheg Souka, Eman Elsayed, Shaimaa Mohamed, Reem Mahmoud Fathalla

Research paper

DOI: 10.5603/DK.a2021.0009

Type one diabetes and autoimmune-related conditions: a Portuguese research in pediatric age

Vanessa Oliveira Gorito, Miguel Bernardo, André Almeida, Cristina Cândido, Vânia Martins

Research paper

DOI: 10.5603/DK.a2021.0031

The relationship between Nrf2/Keap1 system and endoplasmic reticulum stress and inflammatory markers in peripheral blood mononuclear cells of type 2 diabetic subjects

Farshad Niazpour, Hosein Hoseini, ShadiSadat Seyyedebrahimi, Ensieh Nasli Esfahani, Reza Meshkani

Research paper

DOI: 10.5603/DK.a2021.0032

Comparison the health related quality of life in type 2 diabetic patients and healthy people: A Cross-Sectional Study in Iran

Mostafa Bijani, Aboubakr Jafarnejad, Mohammad Rafi Bazrafshan, Sanaz Atef, Parisa Sabet Sarvestani, Azizallah Dehghan

Research paper

DOI: 10.5603/DK.a2021.0047

Safety and Tolerability of Sodium Glucose Co-transporter -2 Inhibitors (SGLT2i) During Ramadan Fasting

Elsayed A. Eid, Abdelaziz M. Hussein, Hossam A. Ghazy

Research paper

DOI: 10.5603/DK.a2021.0048
Review

Metformin therapy and severity and mortality of SARS-CoV-2 infection: a meta-analysis

Teodoro J. Oscanoa, José Amado, Xavier Vidal, Andrea Savarino, Roman Romero-Ortuno

Review paper

DOI: 10.5603/DK.a2021.0035

The effect of chamomile intake on lipid profile in diabetics: A systematic review and meta-analysis of randomized controlled trials

Zahra Mosallanezhad, Marzieh Mahmoodi, Razieh Hosseini, Sara Ranjbar, Mohammad Ali Mirshekar, Cain C.T. Clark, Kamyar Kiamarzi, Faezeh Barzegar, Zahra Motamed, Mohammad Jalali

Review paper

DOI: 10.5603/DK.a2021.0034
ORIGINAL ARTICLES

A study of combined oral anti-diabetic drugs during Ramadan

Majid Alabbood, Nassar Alibrahim, Haider Alidrisi, Ali Alhamza, Ammar Almomin, Ibrahim Hussein

Research paper

DOI: 10.5603/DK.a2021.0028

Autoantibodies in Moroccan patients with type 1 diabetes: Which one to choose?

Faycal El Guendouz, Sara Derrou, Yousra Benabdelfedil, Hassan Ouleghzal, Somaya Safi

Research paper

DOI: 10.5603/DK.a2021.0030

Serum Adenosine Deaminase and C - reactive protein in Diabetic patients with and without Neuropathy

Mansoor Khan, Anju Muraleedharan, Saleena Ummer Velladath, Manjunath Hande

Research paper

DOI: 10.5603/DK.a2021.0046

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl